[96a5a0]: / output / allTrials / identified / NCT02542501_identified.json

Download this file

235 lines (235 with data), 10.2 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
{
"info": {
"nct_id": "NCT02542501",
"official_title": "A Prospective Post Marketing Non Interventional Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive LHRH Analogues and to Evaluate the Effect of LHRH Analogues on Lower Urinary Tract Symptoms (ANALUTS Study)",
"inclusion_criteria": "* Adult men with locally advanced or metastatic prostate cancer scheduled to receive LHRH analogues. A patient who has completed an IPSS questionnaire in his last visit, before the start of LHRH analogues, will be able to participate in the study. This last visit has to be done 6 months before the baseline visit.\n* Patients having provided written informed consent\n* Patients mentally fit for completing a self-administered questionnaire\nHealthy volunteers allowed\nMust be MALE",
"exclusion_criteria": "* Any surgical or radiotherapy treatment performed at prostate level before the entry of the study\n* Patient with castrate levels of testosterone ( < 50 ng/dL) at his first IPSS questionnaire\n* Patients who are also participating in any other clinical study within the last 2 months before study entry\n* Life expectancy of less than 12 months",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Adult men with locally advanced or metastatic prostate cancer scheduled to receive LHRH analogues. A patient who has completed an IPSS questionnaire in his last visit, before the start of LHRH analogues, will be able to participate in the study. This last visit has to be done 6 months before the baseline visit.",
"criterions": [
{
"exact_snippets": "Adult men",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected gender",
"expected_value": "male"
}
]
},
{
"exact_snippets": "Adult men",
"criterion": "age group",
"requirements": [
{
"requirement_type": "expected age group",
"expected_value": "adult"
}
]
},
{
"exact_snippets": "locally advanced or metastatic prostate cancer",
"criterion": "prostate cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"locally advanced",
"metastatic"
]
}
]
},
{
"exact_snippets": "scheduled to receive LHRH analogues",
"criterion": "treatment plan",
"requirements": [
{
"requirement_type": "planned treatment",
"expected_value": "LHRH analogues"
}
]
},
{
"exact_snippets": "completed an IPSS questionnaire",
"criterion": "IPSS questionnaire completion",
"requirements": [
{
"requirement_type": "completion status",
"expected_value": true
}
]
},
{
"exact_snippets": "This last visit has to be done 6 months before the baseline visit",
"criterion": "timing of last visit",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Patients having provided written informed consent",
"criterions": [
{
"exact_snippets": "Patients having provided written informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "provision",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients mentally fit for completing a self-administered questionnaire",
"criterions": [
{
"exact_snippets": "mentally fit for completing a self-administered questionnaire",
"criterion": "mental fitness",
"requirements": [
{
"requirement_type": "capability",
"expected_value": "completing a self-administered questionnaire"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": "Must be MALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "male"
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Any surgical or radiotherapy treatment performed at prostate level before the entry of the study",
"criterions": [
{
"exact_snippets": "surgical ... treatment performed at prostate level",
"criterion": "surgical treatment at prostate level",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "radiotherapy treatment performed at prostate level",
"criterion": "radiotherapy treatment at prostate level",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Patient with castrate levels of testosterone ( < 50 ng/dL) at his first IPSS questionnaire",
"criterions": [
{
"exact_snippets": "castrate levels of testosterone ( < 50 ng/dL)",
"criterion": "testosterone level",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 50,
"unit": "ng/dL"
}
}
]
}
]
},
{
"line": "* Patients who are also participating in any other clinical study within the last 2 months before study entry",
"criterions": [
{
"exact_snippets": "Patients who are also participating in any other clinical study within the last 2 months before study entry",
"criterion": "participation in other clinical study",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 2,
"unit": "months"
}
]
}
}
]
}
]
},
{
"line": "* Life expectancy of less than 12 months",
"criterions": [
{
"exact_snippets": "Life expectancy of less than 12 months",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": "<",
"value": 12,
"unit": "months"
}
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}